TAG:
lab test
Business Buzz Saw Hits Anatomic Path Firms
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: In recent years, both companies have enjoyed sustained and rapid growth in offering anatomic pathology (AP) services nationally. The departure of CFOs from both companies, each for different reasons, is a sign that such unbridled growth has created unique problems for each AP…
Commercial Lab JVs With Hospitals Are Declining In Number
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: There are many reasons why a properly-designed and well-managed laboratory test joint venture (JV) between a commercial lab company and a hospital should succeed. But no matter how strong such concepts look on paper, the real world has proven to be a harsh environment. A hand…
Pharmacy Web-Ordering Now A Physician Priority
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
STRONG PRESSURES ARE MOTIVATING office-based physicians to adopt electronic ordering for prescriptions. In part, this is because of the drive to eliminate unnecessary medical errors. Estimates are that 6% of the nation’s physicians now use an electronic method to order prescriptions for their pati…
Sigma-Aldrich, Ivax Diagnostics, i-STAT, Quest Diagnostics, Unilab
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
SIGMA-ALDRICH SELLS ITS EIA PRODUCT LINE TO IVAX DIAGNOSTICS FOLLOWING ITS DECISION TO EXIT the clinical diagnostics market, Sigma-Aldrich, Inc. has sold its global enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc., based in Miami, Florida. Th…
Survivor: Story of the Nation’s Largest Lab Firm
By R. Lewis Dark | From the Volume IX No. 7 – May 13, 2002 Issue
TELEVISION’S “SURVIVOR” IS THE UNFOLDING STORY of how one person competes to outlast 16 fellow players in a remote outdoor setting. The winner of “Survivor” walks away with a $1 million prize. The show has proven to be popular and is now airing episodes of its fourth group of competitors, s…
More Lab Consolidation: LabCorp Buys Dynacare
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: Recent weeks brought many rumors about an impending deal between Laboratory Corporation of America and Dynacare. That speculation was ended last week when it was disclosed that LabCorp would pay about $685 million in cash, stock and assumed debt to acquire Dynacare. The acqui…
High Cost of New Assays Stretching Lab Budgets
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: Growing numbers of hospital labs report that higher costs of new diagnostic tests have become a new management problem. That’s because diagnostic manufacturers are developing tests around a new business model, one that calls for higher pricing based on a premise of higher c…
Is Physicians’ Office Testing Evolving Toward an Oligopoly?
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: One of the most unpopular industries with consumers is the airline industry. At the national level, it is an oligopoly—dominated by seven carriers. But in many cities, it is a monopoly, with one airline flying 80% of the seats in and out of town. Ongoing consolidation of re…
California Is Lab Industry’s Bellwether Again
By R. Lewis Dark | From the Volume IX No. 6 – April 22, 2002 Issue
IT’S NO COINCIDENCE THAT two recent lab industry developments are centered around lab companies in California. Repeatedly that state has proven to be a valuable bellwether of lab industry trends for the nation. On the lab regulatory front, state officials from the California Department of …
State, Federal Regulators Target Specialty Labs
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Specialty Laboratories, Inc. has earned the dubious honor of being the first-ever publicly-traded laboratory to have its CLIA-88 license revoked by federal regulators, terminating its right to payment for services covered by Medicare and Medicaid. The revocation is slated to …
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized